Mobile website
Prompt Report
Antigenic epitopes of anti-CD40 monoclonal antibody (5C11) analyzed by computer modeling and site-directed mutagenesis
- Article
- Figures
- Metrics
- Preview PDF
- Reference
- Related
- Cited by
- Materials
Abstract:
Objective: To primarily identify the antigenic epitopes of agonist type anti-CD40 monoclonal antibody, 5C11, which was constructed in our previous research, by means of computer modeling and site-directed mutation experiments. Methods:The structures of antigen and antibody were modeled by Insight Ⅱ software and the immune complex was constructed. The antigenic epitope of 5C11 antibody was calculated and speculated. The full length of wide type human CD40 (wtCD40) gene and two site-directed mutant CD40 gene (70muCD40 and 114muCD40) were amplified by RT-PCR; pIRES2-EGFP/wtCD40, pIRES2-EGFP/70muCD40 and pIRES2-EGFP/114muCD40 recombinant vectors were constructed. These vectors were transfected into HEK293 cells by Lipofect method, and HEK293 cells stably transfected with pIRES2-EGFP/wtCD40, pIRES2-EGFP/70muCD40 and pIRES2-EGFP/114muCD40 vectors (named HEK293/wtCD40, HEK293/70muCD40 and HEK293/114muCD40 cells, respectively) were screened. The binding abilities of HEK293/wtCD40, HEK293/70muCD40 and HEK293/114muCD40 cells with 5C11 were examined by flow cytometry and Western blotting analysis. Results: The recombinant eukaryotic expression vectors pIRES2-EGFP/wtCD40, pIRES2-EGFP/70muCD40 and pIRES2-EGFP/114muCD40 were successfully constructed and the corresponding stably transfected HEK293 cells were obtained. The binding ability between 5C11 antibody and HEK293/70muCD40 and HEK293/114muCD40 cells were lower than that with HEK293/wtCD40 cells. Western blotting results showed that 5C11 antibody only recognized HEK293/wtCD40 cells but not HEK293/70muCD40 and HEK293/114muCD40 cells. Conclusion: The 70th threonine and 114th glutamic acids in human CD40 amino acid sequence are the antigenic epitopes of 5C11 monoclonal antibody, which has potential clinical significance for humanized CD40 antibody research.
Keywords:
Project Supported:
Project supported by the Special and Important Program for "Creation of New Drug"(No. 2009zx09103), the Foundation for Innovative Research Team of Ministry of Education (No. IRT0849), and the Foundation for Advanced Research of National Defense (No. B3820110002)
Clc Number:
